Bacitracin
1、Nomenclature
English name:Bacitracin
2、Structural formula
Molecular Structure | |
Molecular formula of Bacitracin A:C66H103N17O16S
Molecular weight of Bacitracin A:1422.69
CAS号CAS No.:1405-87-4
3、Mechanism and clinical use:
Bacitracin is used in medicine as a polypeptide antibiotic. Bacitracin has bactericidal action for Gram-positive bacteria & Gram-negative coccobacteria, diplococcus lanceolatus, staphylococcus, gonococcus, diplococcus intracellularis, leptospiral, etc. The mechanism of action: act on cell wall and effect protoplast, damage cellular plasma membrane and effect permeability.
It is mainly used for infection of penicillin-resistant staphylococcus, also used for skin infection, etc. Under specific concentration, it has relatively strong bactericidal action for systemic infection and topical infection. Its antibacterial spectrum is similar to penicillin G. It is often used by combination with polymyxin, neomycin.
4、Packaging size specification
Inner package: single-layer polyethylene bag and aluminum foil bag.
Outer package: fiber drum.
Packaging size: 10 Kg/drum
The product is mainly used as an animal growth promoter in feed. Due to the presence of zinc, cadmium and mercury salts, the activity of the product is enhanced, so the zinc and manganese salts of the product are often used as feed additives. Growth promoters are non nutritive additives, which can stimulate the growth of livestock and poultry, improve the rate of weight gain and feed utilization, and improve the health of livestock and poultry. It has strong antibacterial activity against most Gram-positive bacteria, similar to penicillin, and also effective against penicillin resistant Staphylococcus aureus. As a drug, it is mainly used to treat various infections caused by drug-resistant staphylococcus aureus, such as sepsis, pneumonia, endocarditis, etc.
IUPAC
(4S)-4-[[(2S)-2-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2R,3S)-1-[[(3R,6R,9R,12R,15R,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
SMILES
CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4